| 1 | positive regulation of growth hormone secretion (GO:0060124) | 8.56505749 |
| 2 | growth hormone secretion (GO:0030252) | 7.86261904 |
| 3 | NIK/NF-kappaB signaling (GO:0038061) | 7.65302545 |
| 4 | natural killer cell differentiation (GO:0001779) | 6.65165171 |
| 5 | determination of adult lifespan (GO:0008340) | 6.42971720 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.96462561 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.80302918 |
| 8 | negative T cell selection (GO:0043383) | 5.74767973 |
| 9 | regulation of growth hormone secretion (GO:0060123) | 5.65436343 |
| 10 | negative thymic T cell selection (GO:0045060) | 5.64996090 |
| 11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.06193389 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.98976336 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.98976336 |
| 14 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.97861605 |
| 15 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 4.86261616 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.72400849 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.62980651 |
| 18 | nucleoside diphosphate catabolic process (GO:0009134) | 4.61544648 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.61385272 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.59512144 |
| 21 | positive T cell selection (GO:0043368) | 4.58511474 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.57955356 |
| 23 | thymic T cell selection (GO:0045061) | 4.55227156 |
| 24 | negative regulation of phagocytosis (GO:0050765) | 4.49686154 |
| 25 | regulation of RIG-I signaling pathway (GO:0039535) | 4.47514790 |
| 26 | regulation of T cell tolerance induction (GO:0002664) | 4.30638450 |
| 27 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.21561681 |
| 28 | T cell selection (GO:0045058) | 4.13732335 |
| 29 | female mating behavior (GO:0060180) | 4.10758062 |
| 30 | regulation of female receptivity (GO:0045924) | 4.09283725 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07418963 |
| 32 | positive regulation of tolerance induction (GO:0002645) | 4.03343774 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98369169 |
| 34 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.94597018 |
| 35 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.93755964 |
| 36 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.91186988 |
| 37 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.91186988 |
| 38 | regulation of G0 to G1 transition (GO:0070316) | 3.87856747 |
| 39 | T cell receptor signaling pathway (GO:0050852) | 3.86464813 |
| 40 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.84423805 |
| 41 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.81969637 |
| 42 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.76365153 |
| 43 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.75958878 |
| 44 | Peyers patch development (GO:0048541) | 3.75958878 |
| 45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75738857 |
| 46 | actin nucleation (GO:0045010) | 3.75688105 |
| 47 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.75071540 |
| 48 | positive regulation of granulocyte differentiation (GO:0030854) | 3.73925137 |
| 49 | response to UV-C (GO:0010225) | 3.70668268 |
| 50 | autophagic vacuole fusion (GO:0000046) | 3.66279292 |
| 51 | glomerular visceral epithelial cell development (GO:0072015) | 3.65635728 |
| 52 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.62980082 |
| 53 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.60049931 |
| 54 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.59680385 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.59013307 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.59006608 |
| 57 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.58817490 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.57917535 |
| 59 | regulation of regulatory T cell differentiation (GO:0045589) | 3.57760376 |
| 60 | lymph node development (GO:0048535) | 3.52966787 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.49666318 |
| 62 | activated T cell proliferation (GO:0050798) | 3.46154895 |
| 63 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.45035894 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43309792 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.42704983 |
| 66 | response to interleukin-15 (GO:0070672) | 3.40327817 |
| 67 | activation of adenylate cyclase activity (GO:0007190) | 3.40265970 |
| 68 | regulation of necroptotic process (GO:0060544) | 3.39881066 |
| 69 | natural killer cell activation (GO:0030101) | 3.37032716 |
| 70 | negative regulation of Ras GTPase activity (GO:0034261) | 3.33738352 |
| 71 | regulation of cell killing (GO:0031341) | 3.33301888 |
| 72 | regulation of metalloenzyme activity (GO:0048552) | 3.33145343 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32886853 |
| 74 | tolerance induction (GO:0002507) | 3.31589640 |
| 75 | respiratory burst (GO:0045730) | 3.31127120 |
| 76 | I-kappaB phosphorylation (GO:0007252) | 3.27907817 |
| 77 | T cell migration (GO:0072678) | 3.27498131 |
| 78 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.26467300 |
| 79 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 3.24225836 |
| 80 | positive regulation of cell killing (GO:0031343) | 3.21880189 |
| 81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.21137580 |
| 82 | glomerular epithelial cell development (GO:0072310) | 3.19408999 |
| 83 | regulation of protein heterodimerization activity (GO:0043497) | 3.14642412 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 3.12524381 |
| 85 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.11390868 |
| 86 | adaptation of signaling pathway (GO:0023058) | 3.11114583 |
| 87 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.08328067 |
| 88 | negative regulation of telomere maintenance (GO:0032205) | 3.08138822 |
| 89 | regulation of B cell differentiation (GO:0045577) | 3.05807309 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 3.02251491 |
| 91 | neutrophil activation involved in immune response (GO:0002283) | 3.01206581 |
| 92 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00705209 |
| 93 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00705209 |
| 94 | modulation by symbiont of host immune response (GO:0052553) | 3.00705209 |
| 95 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00705209 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 3.00705209 |
| 97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00705209 |
| 98 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.99073856 |
| 99 | type I interferon signaling pathway (GO:0060337) | 2.98743385 |
| 100 | cellular response to type I interferon (GO:0071357) | 2.98743385 |
TRBV23-1 
